| Abstrakt: |
A recent study conducted by researchers at the University of Sonora in Mexico explored the proteome of extracellular vesicles (EVs) in patients with type 2 diabetes (T2D). The study aimed to identify proteins that could serve as potential risk markers for the development and progression of T2D. Through a systematic review and bioinformatics analysis, the researchers identified changes in the levels of 426 proteins in the plasma or serum of T2D patients. Proteins such as CST6, CD55, HBA1, S100A8, and S100A9 were found to have high levels, while FGL1 exhibited low levels. These proteins are implicated in pathophysiological mechanisms such as inflammation, complement, and platelet activation. Further research is needed to explore this topic in greater detail. [Extracted from the article] |
